ArticleFrontiers in neuroscience2026
Vagus Nerve Stimulation differentially modulates P3b in responders and non-responders: toward a biomarker of therapeutic efficacy.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Although vagus nerve stimulation (VNS) is an established therapy for drug-resistant epilepsy, its mechanisms of action remain unresolved, resulting in variable clinical efficacy. Given the strong anatomical and functional coupling between vagal afferents and the locus coeruleus-noradrenergic system, this study investigated whether VNS directly impacts an electrophysiological marker of this system, the P3b event-related potential, and how such modulation relates to therapeutic outcomes. Methods: Fifteen adults who had undergone long-term VNS implantation performed an auditory oddball task with the device disabled (OFF) and enabled (ON), with ON separated into electrical pulse-train (ON HIGH) and inter-burst break (ON LOW) phases to investigate the direct impact of electrical stimulation on the P3b. Results: Linear mixed-effects modelling revealed a significant interaction between VNS condition and clinical response: responders showed reduced P3b amplitude ( Discussion: These findings demonstrate that VNS elicits group-specific acute effects on cognitive-electrophysiological markers and support P3b modulation as a promising biomarker for predicting therapeutic efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.